exit_to_appLogin
forum

JAGSNPHARM Share Price Discussion

Jagsonpal Pharmaceuticals Ltd.
Sector: Pharmaceuticals and health care
... Read more
JAGSNPHARM Share Price *
25.35 +0.6 (2.42%)
* (quote may be delayed)

JAGSNPHARM Discussion Forum

  • JAGSNPHARM - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization68.91
    Enterprise Value34.17
    Price to Earnings8.41
    Price to Book Value0.66
    Return on Capital Employed-0.11
    Return on Equity-0.13
    Face Value5
    Dividend YieldNA

  • JAGSNPHARM Share Price - Technicals

    keyboard_arrow_down
    JAGSNPHARM - 52 Week High₹32.7
    JAGSNPHARM - 52 Week Low₹20.2

  • JAGSNPHARM Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 1824.7525.524.0525.35
    Sep 1725.6525.8523.7524.75
    Sep 1625.2526.7524.125.85
    Sep 1325.126.124.9525.25
    Sep 1228.728.924.7524.95

  • JAGSNPHARM Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹23.43
    30 Day Moving Average₹23.3
    50 Day Moving Average₹23.52
    100 Day Moving Average₹24.96
    200 Day Moving Average₹26.89

  • JAGSNPHARM - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue126.53143.87-0.12
    Operating Profit-11.115.76-2.93
    Profit Before Tax-11.6314.4-1.81
    Net Income-11.5511.86-1.97

  • JAGSNPHARM - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds104.4790.210.16
    Total Liabilities31.3139.61-0.21
    Total Assets135.78129.820.05

  • JAGSNPHARM - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity-1.58-3.24-0.51
    Cash from Investing Activity-3.3741.29-1.08
    Cash from Financing Activity-0.6-33.52-0.98
    Net Cash Flow-5.554.53-2.23

  • JAGSNPHARM - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.090.08
    Return on Equity-0.130.12
    Return on Capital Employed-0.110.15

  • JAGSNPHARM - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.08
    3 Year CAGR Growth in Operating Profit-2.27
    3 Year CAGR Growth in EBIDTA-2.2
    3 Year CAGR Growth in Net Income-10.87
    3 Yr CAGR Growth - Diluted EPS-11.02

  • JAGSNPHARM - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.24
    5 Year CAGR Growth in Operating Profit-2.11
    5 Year CAGR Growth in EBIDTA-2.03
    5 Year CAGR Growth in Net Income-7.31
    3 Yr CAGR Growth - Diluted EPS-7.3

  • JAGSNPHARM Share Price - Recent News

    keyboard_arrow_down

  • JAGSNPHARM - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
HelpAboutPrivacyTermsDisclaimersRefunds